Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.benzinga.com/pressreleases/22/09/g29091284/zealand-pharma-announces-positive-results-from-phase-3-trial-of-glepaglutide-in-patients-with-shor

BENZINGA
01 Oct 2022

https://www.globenewswire.com/news-release/2022/03/11/2401950/0/en/Correction-Zealand-Pharma-Significant-Advancement-of-Clinical-Pipeline-and-Building-Commercial-Momentum-Key-Data-for-Glepaglutide-and-Dasiglucagon-Programs-Expected-in-2022.html

GLOBENEWSWIRE
11 Mar 2022

https://www.pharmacompass.com/pdf/news/zealand-pharma-completes-enrollment-in-ease-sbs-1-phase-3-trial-assessing-glepaglutide-in-patients-with-short-bowel-syndrome-1643725656.pdf

PRESS RELEASE
20 Jan 2022

https://www.globenewswire.com/news-release/2021/08/19/2283569/0/en/Zealand-Pharma-Announces-First-Patient-Dosed-in-EASE-SBS-4-Phase-3b-Trial-Assessing-Glepaglutide-in-Patients-with-Short-Bowel-Syndrome.html

GLOBENEWSWIRE
19 Aug 2021

https://www.globenewswire.com/news-release/2021/06/29/2254571/0/en/Zealand-Pharma-to-Present-Data-on-Glepaglutide-at-the-17th-Congress-of-the-Intestinal-Rehabilitation-and-Transplantation-Association-CIRTA.html

GLOBENEWSWIRE
29 Jun 2021